INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3096% above fair value
$144.46+24.66 (+20.58%)
Close on Nov 19, 2026Market cap $31.69BP/E –Yield –
Insmed shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Insmed's shares outstanding was 219M at Sep 30, 2026. For fiscal 2025 it was 199M, up 21.3% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 199M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 199M | +21.3% |
| FY2024 | Dec 31, 2024 | 164M | +16.8% |
| FY2023 | Dec 31, 2023 | 140M | +14.1% |
| FY2022 | Dec 31, 2022 | 123M | +9.7% |
| FY2021 | Dec 31, 2021 | 112M | +14.9% |
| FY2020 | Dec 31, 2020 | 98M | +15.4% |
| FY2019 | Dec 31, 2019 | 85M | +10.0% |
| FY2018 | Dec 31, 2018 | 77M | +15.5% |
| FY2017 | Dec 31, 2017 | 67M | +7.6% |
| FY2016 | Dec 31, 2016 | 62M | +5.6% |
| FY2015 | Dec 31, 2015 | 59M | +36.1% |
| FY2014 | Dec 31, 2014 | 43M | +23.2% |
| FY2013 | Dec 31, 2013 | 35M | +31.8% |
| FY2012 | Dec 31, 2012 | 27M | +13.7% |
| FY2011 | Dec 31, 2011 | 23M | +76.2% |
| FY2010 | Dec 31, 2010 | 13M | +104009.4% |
| FY2009 | Dec 31, 2009 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 219M | +3.3% |
| Q2 FY2026 | Jun 30, 2026 | 217M | +14.8% |
| Q1 FY2026 | Mar 31, 2026 | 215M | +19.1% |
| Q4 FY2025 | Dec 31, 2025 | 214M | +19.3% |
| Q3 FY2025 | Sep 30, 2025 | 212M | +21.9% |
| Q2 FY2025 | Jun 30, 2025 | 189M | +22.4% |
| Q1 FY2025 | Mar 31, 2025 | 181M | +21.8% |
| Q4 FY2024 | Dec 31, 2024 | 179M | +23.7% |
| Q3 FY2024 | Sep 30, 2024 | 174M | +21.6% |
| Q2 FY2024 | Jun 30, 2024 | 155M | +12.5% |
| Q1 FY2024 | Mar 31, 2024 | 148M | +8.9% |
| Q4 FY2023 | Dec 31, 2023 | 145M | +9.1% |
| Q3 FY2023 | Sep 30, 2023 | 143M | +18.3% |
| Q2 FY2023 | Jun 30, 2023 | 138M | +15.0% |
| Q1 FY2023 | Mar 31, 2023 | 136M | +14.7% |
| Q4 FY2022 | Dec 31, 2022 | 133M | +12.0% |
| Q3 FY2022 | Sep 30, 2022 | 121M | +3.2% |
| Q2 FY2022 | Jun 30, 2022 | 120M | +9.1% |
| Q1 FY2022 | Mar 31, 2022 | 119M | +15.4% |
| Q4 FY2021 | Dec 31, 2021 | 119M | +15.9% |
| Q3 FY2021 | Sep 30, 2021 | 117M | +15.2% |
| Q2 FY2021 | Jun 30, 2021 | 110M | +13.4% |
| Q1 FY2021 | Mar 31, 2021 | 103M | +14.8% |
| Q4 FY2020 | Dec 31, 2020 | 102M | +14.3% |
| Q3 FY2020 | Sep 30, 2020 | 102M | +13.9% |
| Q2 FY2020 | Jun 30, 2020 | 97M | +18.1% |
| Q1 FY2020 | Mar 31, 2020 | 90M | +15.8% |
| Q4 FY2019 | Dec 31, 2019 | 90M | +16.1% |
| Q3 FY2019 | Sep 30, 2019 | 89M | +15.8% |
| Q2 FY2019 | Jun 30, 2019 | 82M | +6.6% |
| Q1 FY2019 | Mar 31, 2019 | 78M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | 77M | +0.5% |
| Q3 FY2018 | Sep 30, 2018 | 77M | +18.0% |
| Q2 FY2018 | Jun 30, 2018 | 77M | +23.4% |
| Q1 FY2018 | Mar 31, 2018 | 77M | +23.5% |
| Q4 FY2017 | Dec 31, 2017 | 77M | +23.8% |
| Q3 FY2017 | Sep 30, 2017 | 65M | – |
| Q2 FY2017 | Jun 30, 2017 | 62M | – |
| Q1 FY2017 | Mar 31, 2017 | 62M | – |
| Q4 FY2016 | Dec 31, 2016 | 62M | – |
See a number that looks wrong?